Cite

HARVARD Citation

    Takamori, H. et al. (2023). Development of drugs targeting hypoxia‐inducible factor against tumor cells with VHL mutation: Story of 127 years. Cancer science. 114 (4), pp. 1208-1217. [Online]. 
  
Back to record